3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Dyspepsia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boeckxstaens, GE; Booij, J; Braak, B; Klooker, TK; van den Wijngaard, RM | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dyspepsia
Article | Year |
---|---|
The dopaminergic system in patients with functional dyspepsia analysed by single photon emission computed tomography (SPECT) and an alpha-methyl-para-tyrosine (AMPT) challenge test.
Topics: Adolescent; Adult; Aged; alpha-Methyltyrosine; Benzamides; Case-Control Studies; Dopamine; Drinking; Dyspepsia; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Postprandial Period; Prolactin; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Young Adult | 2012 |